secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rani Therapeutics Holdings, Inc. (RANI)
CIK:        0001856725
Form:       8-K
Filed at:   2022-01-05T23:59:59+00:00
Accession:  0001193125-22-002651
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Rani Therapeutics elects Lisa Rometty to board of directors
-----------------------------------------------------------

- Lisa Rometty elected director effective Jan 3, 2022; term expires at next annual meeting.
- Granted nonqualified stock options for 49,037 shares at $17.00 exercise price, vesting over 3 years.
- Compensation per standard non-employee director policy; standard indemnification agreement executed.
- No arrangement or understanding with others for election; no related-party transactions disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856725/000119312522002651/0001193125-22-002651-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856725/000119312522002651/d281285d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-002651

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer